Summary
Human neutrophils possess an NADPH oxidase which catalyzes superoxide (O sup−inf2 ) formation and is activated by chemotactic peptides. Histamine inhibits O sup−1inf2 formation via H2-receptors (Burde et al. 1989). We characterized the neutrophil H2-receptor with a series of new guanidine-type H2-agonists structurally derived from impromidine. Histamine inhibited O sup−inf2 formation with an IC50 value of 6.7 ± 1.2 μM. Five aryloxy- and arylthioalkylguanidines were less potent and effective than histamine. Several arpromidine-like phenyl(pyridylalkyl)guanidines were either full or partial H2-agonists. Some guanidines possess a three-membered carbon chain connecting the aromatic rings and the guanidine group; they were similarly potent and effective as histamine. Shortening or elongation of the carbon chain substantially decreased the potency and intrinsic activity of the guanidines. Halogenation of the phenyl ring did not substantially affect the potency and intrinsic activity of the compounds in comparison to the non-substituted parent compound. The H2-antagonist, famotidine, competitively antagonized inhibition of O sup−inf2 formation caused by the guanidine, arpromidine, with a pA2 value of 6.84. The H2-antagonist, cimetidine, differentially counteracted inhibition caused by partial and full H2-agonists. Partial H2-agonists antagonized the effects of histamine. The inhibitor of phosphodiesterases, 3-isobutyl-lmethylxanthine, additively enhanced the inhibitory effects of histamine and guanidines. The properties of the neutrophil H2-receptor were compared with literature data concerning properties of the H2-receptor of the guinea pig atrium. In the latter system, guanidines are full H2-agonists with potencies of up to 125-fold of that of histamine. Our data indicate that guanidines inhibit O sup−inf2 formation in human neutrophils via H2-receptors. The structure/activity relationship for the neutrophil H2-receptor substantially differs from the one for the H2-receptor in the guinea pig atrium, suggesting that the neutrophil H2-receptor has cell type-specific properties. Other possibilities to explain the differences between H2-receptors in these systems are discussed.
Similar content being viewed by others
References
Arrang J-M, Garbarg M, Lancelot J-C, Lecomte J-M, Pollard H, Robba M, Schunack W, Schwartz J-C (1987) Highly potent and selective ligands for histamine H3-receptors. Nature 327:117–123
Bertaccini G, Coruzzi G (1981) Effect of impromidine (SK & F 92676) on the isolated papillary muscle of the guinea pig. Br J Pharmacol 72:197–199
Bertaccini G, Coruzzi G (1983) Histamine H2-receptors: a homogeneous population? Ital J Gastroenterol 15:51–58
Black JW, Duncan WAM, Durant GJ, Ganellin CR, Parsons ME (1972) Definition and antagonism of histamine H2-receptors. Nature 236:385–390
Burde R, Seifert R, Buschauer A, Schultz G (1989) Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 340:671–678
Buschauer A (1988a) Synthese positiv inotroper Substanzen: Aryloxyalkylguanidine. Arch Pharm (Weinheim) 321:281–285
Buschauer A (1988b) Phenoxy- and phenylthioalkylguanidines: synthesis and in vitro pharmacology. Eur J Med Chem 23:1–6
Buschauer A (1988c) Synthese positiv inotroper Substanzen: Imidazolylpropylguanidine mit Pyridin-Partialstruktur. Arch Pharm (Weinheim) 321:415–418
Buschauer A (1989) Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs. J Med Chem 32:1963–1970
Buschauer A, Schunack W, Arrang J-M, Garbarg M, Schwartz JC, Young JM (1989) Histamine receptors. In: Williams M, Glennon RA, Timmermans PBMWM (eds) Receptor pharmacology and function. Clinical pharmacology, vol 13. Marcel Dekker, New York, pp 293–348
Durant GJ, Duncan WAM, Ganellin CR, Parsons ME, Blakemore RC, Rasmussen AC (1978) Impromidine (SK & F 92676) is a very potent and specific agonist for histamine H2 receptors. Nature 276:403–405
Fagot D, Emami S, Chastre E, Bawab W, Gespach C (1988) Pharmacological control of the histamine H2-receptor-adenylate cyclase system by famotidine and ranitidine in normal and cancerous human gastric epithelia. Agents Actions 23:293–296
Gerhard G, Schunack W (1980) Struktur-Wirkungs-Beziehungen bei Histaminanaloga. Absolute Konfiguration und histaminartige Wirkung der enantiomeren α-Methylhistamine. Arch Pharm (Weinheim) 313:709–714
Gespach C, Abita J-P (1982) Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP. Mol Pharmacol 21:78–85
Gespach C, Saal F, Cost H, Abita J-P (1982) Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils. Mol Pharmacol 22:547–553
Gespach C, Launay J-M, Emami S, Bondoux D, Dreux C (1986) Biochemical and pharmacological characterization of histamine-mediated up-regulation of human platelet serotonin uptake. Evidence for a subclass of histamine H2-receptors (H2h) highly sensitive to H2 receptor antagonists. Agents Actions 18:115–119
Iizuka T, Kanegasaki S, Makino R, Tanaka T, Ishimura Y (1985) Pyridine and imidazole reversibly inhibit the respiratory burst in porcine and human neutrophils: evidence for the involvement of cytochrome b558 in the reaction. Biochem Biophys Res Commun 130:621–626
Kartinos JN (1964) Baxter Laboratories. γ-Dimethylaminopropyl-isothiourea and its acid addition salts. US patent 3116327 (1963). Chem Abstr 60:9158d
Khan MM, Melmon KL, Marr-Leisy D, Verlander MS, Egli M, Lok S, Goodman M (1987) Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives. J Med Chem 30:2115–2120
Luchins AR, Makman MH (1980) Presence of histamine and serotonin receptors associated with adenylate cyclase in cultured calf-aorta smooth muscle cells. Pharmacological characterization of the histamine response. Biochem Pharmacol 29:3155–3161
Malech HL, Gallin MD (1987) Neutrophils in human diseases. New Engl J Med 317:687–694
Mitsuhashi M, Mitsuhashi T, Payan DG (1989) Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. J Biol Chem 264:18356–18362
Ozaki Y, Kume S, Ohashi T (1984) Effects of histamine agonists and antagonists on luminol-dependent chemiluminescence of granulocytes. Agents Actions 15:182–188
Parsons M, Sykes C (1980) Impromidine (SK & F 92676) acts as a partial agonist on the isolated whole stomach of the rat. Br J Pharmacol 69:6–7
Parsons M, Owen DAA, Ganellin CR, Durant GJ (1977) DimapritS-[3-(N,N-dimethylamino)propyl]isothiourea —a highly specific histamine H2-receptor antagonist. Part I. Pharmacology. Agents Actions 7:31–37
Rising TJ, Steward A (1986) The determination of receptor constants for histamine H2-agonists in the guinea pig isolated right atrium using an irreversible H2-antagonist. Br J Pharmacol 87:211–216
Rossi F (1986) The O −2 -forming NADPH oxidase of phagocytes: nature, mechanisms of activation and function. Biochim Biophys Acta 853:65–89
Schild HO (1947) pA, a new scale for the measurement of drug antagonism. Br J Pharmacol 2:189–206
Schunack W (1987) What are the difference between the H2-receptor antagonists? Aliment Pharmacol Ther 1:4935–5035
Seifert R, Schächtele C (1988) Studies with protein kinase C inhibitors presently available cannot elucidate the role of protein kinase C in the activation of NADPH oxidase. Biochem Biophys Res Commun 152:585–592
Seifert R, Schultz G (1989) Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Pharmacol Sci 10:365–369
Seifert R, Burde R, Schultz G (1989a) Activation of NADPH oxidase by purine and pyrimidine nucleotides involves G proteins and is potentiated by chemotactic peptides. Biochem J 259:813–819
Seifert R, Burde R, Schultz G (1989b) Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells. Naunyn-Schmiedeberg's Arch Pharmacol 340:101–106
Seifert R, Wenzel K, Eckstein F, Schultz G (1989c) Purine and pyrimidine nucleotides potentiate activation of NADPH oxidase and degranulation by chemotactic peptides and induce aggregation of human neutrophils via G proteins. Eur J Biochem 181:277–285
Seligmann BE, Fletcher MP, Gallin JI (1983) Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. J Immunol 130:1902–1909
Tallarida RJ, Jacob LS (1987) pA2 analysis I: schild plot. In: Tallarida RJ, Jacob LS (eds) Manual of pharmacologic calculations with computer programs, 2nd edn. Springer, Berlin Heidelberg New York, pp 53–56
Author information
Authors and Affiliations
Additional information
Send offprint requests to R. Seifert at the above address
Rights and permissions
About this article
Cite this article
Burde, R., Buschauer, A. & Seifert, R. Characterization of histamine H2-receptors in human neutrophils with a series of guanidine analogues of impromidine. Naunyn-Schmiedeberg's Arch Pharmacol 341, 455–461 (1990). https://doi.org/10.1007/BF00176340
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00176340